(Q37218580)

19 August 2017

1 reference

title

Protecting axons in multiple sclerosis (English)

1 reference

19 August 2017

0 references

A Wilkins

1

1 reference

19 August 2017

N Scolding

series ordinal

2

1 reference

19 August 2017

publication date

16 July 2008

1 reference

Multiple Sclerosis Journal

19 August 2017

published in

1 reference

19 August 2017

volume

14

1 reference

19 August 2017

issue

8

1 reference

19 August 2017

page(s)

1013-1025

1 reference

Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Axonal damage in acute multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Neurofascin as a novel target for autoantibody-mediated axonal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Age at disability milestones in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Natural history of multiple sclerosis: a unifying concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

The contribution of demyelination to axonal loss in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

The role of nitric oxide in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Different pathways for iNOS-mediated toxicity in vitro dependent on neuronal maturation and NMDA receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Nitric oxide inhibition of mitochondrial respiration and its role in cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Trophic factors attenuate nitric oxide mediated neuronal and axonal injury in vitro: roles and interactions of mitogen-activated protein kinase signalling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Experimental autoimmune encephalomyelitis repressed by microglial paralysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Lipopolysaccharide increases microglial GLT-1 expression and glutamate uptake capacity in vitro by a mechanism dependent on TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Differential regulation of trophic and proinflammatory microglial effectors is dependent on severity of neuronal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Inflammation stimulates remyelination in areas of chronic demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Imaging axonal damage of normal-appearing white matter in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Local control of neurofilament accumulation during radial growth of myelinating axons in vivo. Selective role of site-specific phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Axonal swellings and degeneration in mice lacking the major proteolipid of myelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Current concepts of PLP and its role in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Evolution of a neuroprotective function of central nervous system myelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

The proteolipid protein gene and myelin disorders in man and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Dysregulation of axonal sodium channel isoforms after adult-onset chronic demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

White matter injury mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Replacing cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

LINGO-1 negatively regulates myelination by oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

The glial response to injury and its role in the inhibition of CNS repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Nerve growth factor signaling, neuroprotection, and neural repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Conditioned media derived from glial cell lines promote survival and differentiation of dopaminergic neurons in vitro: Role of mesencephalic glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Characterization of a neurotrophic factor produced by cultured astrocytes involved in the regulation of subcortical cholinergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Regulation of GDNF expression in cultured astrocytes by inflammatory stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Increased ciliary neurotrophic factor expression in reactive astrocytes following spinal cord injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Astrocytes protect neurons from neurotoxic injury by serum glutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Oligodendrocytes as providers of growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Murine oligodendroglial cells express nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Neuronal signals regulate neurotrophin expression in oligodendrocytes of the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

GDNF family members and their receptors: expression and functions in two oligodendroglial cell lines representing distinct stages of oligodendroglial development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

A role for oligodendrocyte-derived IGF-1 in trophic support of cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Induction of sodium channel clustering by oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Current trials in multiple sclerosis: established evidence and future hopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Cannabinoids and neuroprotection in CNS inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Lentiviral-mediated delivery of Bcl-2 or GDNF protects against excitotoxicity in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Strategies for achieving and monitoring myelin repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Autologous mesenchymal bone marrow stem cells: practical considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Expression of transforming growth factor beta 1 in mesenchymal stem cells: potential utility in molecular tissue engineering for osteochondral repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Bone marrow stromal cells produce nerve growth factor and glial cell line-derived neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Glial cell line-derived neurotrophic factor in bone marrow stromal cells of rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Human bone marrow stroma cells display certain neural characteristics and integrate in the subventricular compartment after injection into the liquor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Neogenesis of cerebellar Purkinje neurons from gene-marked bone marrow cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Bone marrow stromal cells mediate protection through stimulation of PI3-K/Akt and MAPK signaling in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508091370

21 January 2018

Identifiers

DOI

10.1177/1352458508091370

1 reference

19 August 2017

1 reference